|Last Price$24.49||Day Change (%)2.47%|
|Open Price$23.79||Day Change ($)0.59|
|Day Range23.22–24.86||52-Week Range8.99–24.86|
As of Fri 12/19/2014 05:50 PM EST | USD
Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference
Research and Markets: Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...